Epigenetics and autoimmunity, with special emphasis on methylation

Keio Journal of Medicine

Volumn 60, Issue 1, 2011, Pages 10-16

  Renaudineau, Yves ^a   Youinou, Pierre ^a  

^a BREST UNIVERSITY HOSPITAL   (France)

Author keywords

Autoimmune diseases; B cells; Epigenetics; T cells

Indexed keywords

AZACITIDINE; CD40 LIGAND; CD6 ANTIGEN; CD70 ANTIGEN; CELL RECEPTOR; CYTOKINE; DNA GLYCOSYLTRANSFERASE; DNA METHYLTRANSFERASE; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 2; DNA METHYLTRANSFERASE 3 L; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; DNA METHYLTRANSFERASE INHIBITOR; HISTONE H2A; HISTONE H2B; HISTONE H3; HISTONE H4; HYDRALAZINE; INTERLEUKIN 4; INTERLEUKIN 6; METHYL CPG BINDING DOMAIN PROTEIN 4; METHYL CPG BINDING PROTEIN; MICRORNA; PROCAINAMIDE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

AUTOIMMUNITY; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIVISION; CELL MATURATION; DISEASE ACTIVITY; DNA METHYLATION; DNA POLYMORPHISM; DNA REPLICATION; DNA SYNTHESIS INHIBITION; EPIGENETICS; GENE EXPRESSION; GENETIC CODE; GENETIC TRANSCRIPTION; GROWTH DISORDER; HISTONE ACETYLATION; HUMAN; LYMPHOCYTE; MULTIPLE SCLEROSIS; NERVE CELL; NONHUMAN; PROMOTER REGION; REGULATORY T LYMPHOCYTE; RETROVIRUS; REVIEW; RHEUMATOID ARTHRITIS; SYNOVIOCYTE; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; X CHROMOSOME;

ACETYLATION; ANIMALS; ARTHRITIS, RHEUMATOID; AUTOIMMUNITY; B-LYMPHOCYTES; CELL CYCLE; DNA; DNA METHYLATION; DNA MODIFICATION METHYLASES; EPIGENOMICS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; GENE EXPRESSION; HISTONES; HUMANS; INTERLEUKIN-6; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MICE; MULTIPLE SCLEROSIS; PROMOTER REGIONS, GENETIC; T-LYMPHOCYTES; TRANSCRIPTION, GENETIC;

EID: 79955693133     PISSN: 00229717     EISSN: 18801293     Source Type: Journal    
DOI: 10.2302/kjm.60.10     Document Type: Review

References (50)

1. Youinou P, Pers JO, Gershwin ME, Shoenfeld Y: Geoepidemiology and autoimmunity. J Autoimmun 2010; 34: 163-167.
2. Brooks WH, Le Dantec C, Pers JO, Youinou P, Renaudineau Y: Epigenetics and autoimmunity. J Autoimmun 2010; 34: 207-219.
3. Lu Q, Renaudineau Y, Cha S, et al: Epigenetics in autoimmune disorders: highlights of the 10th Sjögren's syndrome symposium. Autoimmun Rev 2010; 9: 627-630.
4. Brown SE, Fraga MF, Weaver IC, Berdasco M, Szyf M: Variations in DNA methylation patterns during the cell cycle of HeLa cells. Epigenetics 2007; 2: 54-65.
5. Li Y, Zhao M, Yin H: Overexpression of the growth arrest and DNA damage-induced 45α gene contributes to autoimmunity by promoting DNA demethylation in T cells. Arthritis Rheum 2010; 62: 1438-1447.
6. Dieker J, Muller S: Epigenetic histone code and autoimmunity. Clin Rev Allergy Immunol 2010; 39: 78-84.
7. Ng HH, Zhang Y, Hendrich B, et al: MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex. Nat Genet 1999; 23: 58-61.
8. Zhang Y, Jurkowska R, Soeroes S, et al: Chromatin methylation of Dnmt3a and Dnmt3a/3L is guided by interaction of the ADD domain with the histone H3 tail. Nucleic Acids Res 2010; 38: 4246-4253.
9. Lindsay MA: MicroRNAs and the immune response. Trends Immunol 2008; 29: 343-351.
10. Mello CC, Conte D Jr: Revealing the world of RNA interference. Nature 2004; 431: 338-342.
11. Han L, Witmer PD, Casey E, Valle D, Sukumar S: DNA methylation regulates microRNA expression. Cancer Biol Ther 2007; 6: 1284-1288.
12. Scott GK, Mattie MD, Berger CE, Benz SC, Benz CC: Rapid alteration of microRNA levels by histone deacetylase inhibition. Cancer Res 2006; 66: 1277-1281.
13. Fraga MF, Ballestar E, Paz MF, et al: Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci U S A 2005; 102: 10604-10609.
14. Bork S, Pfister S, Witt H, Horn P, Korn B, Ho AD, Wagner W: DNA methylation pattern changes upon long-term culture and aging of human mesenchymal stromal cells. Aging Cell 2010; 9: 54-63.
15. Brooks WH: X-chromosome inactivation and autoimmunity. Clin Rev Allergy Immunol 2010; 39: 20-29.
16. Cornacchia E, Golbus J, Maybaum J, Strahler J, Hanash S, Richardson B: Hydralazine and procainamide inhibit T cell DNA methylation and induce autoreactivity. J Immunol 1988; 140: 2197-2200.
17. Richardson B, Cornacchia E, Golbus J, Maybaum J, Strahler J, Hanash S: N-acetylprocainamide is a less potent inducer of T cell autoreactivity than procainamide. Arthritis Rheum 1988; 31: 995-999.
18. Quddus J, Johnson KJ, Gavalchin J, et al: Treating activated CD4+ T cells with either of two distinct DNA methyltransferase inhibitors, 5-azacytidine or procainamide, is sufficient to cause a lupus-like disease in syngeneic mice. J Clin Invest 1993; 92: 38-53.
19. Deininger PL, Batzer MA: Mammalian retroelements. Genome Res 2002; 12: 1455-1465.
20. Lleo A, Invernizzi P, Gao B, Podda M, Gershwin ME: Definition of human autoantibodies versus autoimmune disease. Autoimmun Rev 2010; 9: A259-266.
21. Javierre BM, Fernandez AF, Richter J, et al: Changes in the pattern of DNA methylation associate with twin discordance in SLE. Genome Res 2010; 20: 170-179.
22. Richardson B, Scheinbart L, Strahler J, Gross L, Hanash S, Johnson M: Evidence for impaired T cell DNA methylation in SLE and rheumatoid arthritis. Arthritis Rheum 1990; 33: 1665-1673.
23. Liu Y, Chen Y, Richardson B: Decreased DNA methyltransferase levels contribute to abnormal gene expression in "senescent" CD4(+) CD28(-) T cells. Clin Immunol 2009; 132: 257-265.
24. Lal G, Zhang N, van der Touw W, et al: Epigenetic regulation of Foxp3 expression in regulatory T cells by DNA methylation. J Immunol 2009; 182: 259-273.
25. + T cells of patients with SLE. J Biomed Biotechnol 2010; 2010: 9310-9318.
26. Lu Q, Wu A, Richardson BC: Demethylation of the same promoter sequence increases CD70 expression in lupus T cells and T cells treated with lupus-inducing drugs. J Immunol 2005; 174: 6212-6219.
27. Singer NG, Richardson BC, Powers D, et al: Role of the CD6 glycoprotein in antigen-specific and autoreactive responses of cloned human T lymphocytes. Immunology 1996; 88: 537-543.
28. Lu Q, Wu A, Tesmer L, Ray D, Yousif N, Richardson B: Demethylation of CD40L on the inactive X in T cells from women with lupus. J Immunol 2007; 179: 6352-6358.
29. + T cells of patients with SLE. Clin Rheumatol 2008; 27: 21-27.
30. + T cells from patients with SLE, systemic sclerosis, and dermatomyositis. Scand J Rheumatol 2009; 38: 369-374.
31. Wang GS, Zhang M, Li XP, et al: Ultraviolet B exposure of peripheral blood mononuclear cells of patients with SLE inhibits DNA methylation. Lupus 2009; 18: 1037-1044.
32. Balada E, Ordi-Ros J, Serrano-Acedo S, Martinez-Lostao L, Rosa-Leyva M, Vilardell-Tarrés M: Transcript levels of DNA methyltransferases DNMT1, DNMT3A and DNMT3B in CD4+ T cells from patients with SLE. Immunology 2008; 124: 339-347.
33. Pan W, Zhu S, Yuan M, et al: MicroRNA-21 and microRNA-148a contribute to DNA hypomethylation in lupus CD4+ T cells by directly and indirectly targeting DNMT1. J Immunol 2010; 184: 6773-6781.
34. Balada E, Ordi-Ros J, Serrano-Acedo S, Martinez-Lostao L, Vilardell-Tarrés M: Transcript overexpression of the MBD2 and MBD4 genes in CD4+ T cells from SLE patients. J Leukoc Biol 2007; 81: 1609-1616.
35. Garaud S, Le Dantec C, Jousse-Joulin S, et al: IL-6 modulates CD5 expression in B cells from patients with lupus by regulating DNA methylation. J Immunol 2009; 182: 5623-5632.
36. + T cells. J Rheumatol 2008; 35: 804-810.
37. + cells in SLE. Arthritis Res Ther 2010; 12: 101-103.
38. Lal G, Bromberg JS: Epigenetic mechanisms of regulation of Foxp3 expression. Blood 2009; 114: 3727-3735.
39. Sawalha AH, Harley JB, Scofield RH: Autoimmunity and Klinefelter's syndrome: when men have two X chromosomes. J Autoimmun 2009; 33: 31-34.
40. Youinou P, Renaudineau Y: The paradox of CD5-expressing B cells in SLE. Autoimmun Rev 2007; 7: 149-154.
41. Renaudineau Y, Hillion S, Saraux A, Mageed RA, Youinou P: An alternative exon 1 of the cd5 gene regulates CD5 expression in human B lymphocytes. Blood 2005; 106: 2781-2789.
42. Renaudineau Y, Vallet S, Le Dantec C, Hillion S, Saraux A, Youinou P: Characterization of the CD5 HERV in B lymphocytes. Genes Immun 2005; 6: 663-671.
43. Garaud S, Le Dantec C, Berthou C, Lydyard PM, Youinou P, Renaudineau Y: Selection of the alternative exon 1 from the cd5 gene down-regulates membrane level of the protein in B lymphocytes. J Immunol 2008; 181: 2010-2018.
44. Okada M, Ogasawara H, Kaneko H, et al: Role of DNA methylation in transcription of HERV in the pathogenesis of SLE. J Rheumatol 2002; 29: 1678-1682.
45. Sekigawa I, Okada M, Ogasawara H, Kaneko H, Hishikawa T, Hashimoto H: DNA methylation in SLE. Lupus 2003; 12: 79-85.
46. Hillion S, Dueymes M, Youinou P, Jamin C: IL-6 contributes to the expression of RAGs in human mature B cells. J Immunol 2007; 179: 6790-6798.
47. Hillion S, Garaud S, Devauchelle V, et al: IL-6 is responsible for aberrant B-cell receptor-mediated regulation of RAG expression in systemic lupus erythematosus. Immunology 2007; 122: 371-380.
48. Mazari L, Ouarzane M, Zouali M: Subversion of B lymphocyte tolerance by hydralazine, a potential mechanism for drug-induced lupus. Proc Natl Acad Sci USA 2007; 104: 6317-6322.
49. Renaudineau Y. The revolution of epigenetics in the field of autoimmunity. Clin Rev Allergy Immunol 2010; 39: 1-2.
50. Lu Q, Renaudineau Y, Cha S, et al: Epigenetics in autoimmune disorders: highlights of the 10th Sjögren's syndrome symposium. Autoimmun Rev 2010; 9: 627-630.